MediPal Holdings Corporation Stock Other OTC
Equities
MAHLY
US58502T1079
Pharmaceuticals
Sales 2024 | 3,559B 22.85B 31.1B | Sales 2025 * | 3,573B 22.95B 31.23B | Capitalization | 471B 3.03B 4.12B |
---|---|---|---|---|---|
Net income 2024 | 41.47B 266M 362M | Net income 2025 * | 34.23B 220M 299M | EV / Sales 2024 | 0.14 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.13 x |
P/E ratio 2024 |
11.8
x | P/E ratio 2025 * |
14.2
x | Employees | - |
Yield 2024 |
2.59% | Yield 2025 * |
2.79% | Free-Float | 84.27% |
Managers | Title | Age | Since |
---|---|---|---|
Shuichi Watanabe
CEO | Chief Executive Officer | 72 | 00-03-31 |
Midori Ito
CMP | Compliance Officer | - | - |
Takeshi Yanagida
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Shuichi Watanabe
CEO | Chief Executive Officer | 72 | 00-03-31 |
Toshihide Yoda
ADM | Chief Administrative Officer | 61 | 10-05-31 |
Director/Board Member | 69 | 77-03-31 |
1st Jan change | Capi. | |
---|---|---|
+21.93% | 73.38B | |
-1.71% | 24.13B | |
+7.33% | 8.78B | |
+10.34% | 8.59B | |
-19.80% | 8.06B | |
+14.16% | 5.26B | |
-0.03% | 4.21B | |
+12.70% | 4.17B | |
-2.54% | 3.89B |